263 related articles for article (PubMed ID: 25041068)
1. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
[TBL] [Abstract][Full Text] [Related]
3. Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.
Su J; Gan-Schreier H; Goeppert B; Chamulitrat W; Stremmel W; Pathil A
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347788
[TBL] [Abstract][Full Text] [Related]
4. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
6. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
Pathil A; Warth A; Chamulitrat W; Stremmel W
J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
Ma L; Zeng Y; Wei J; Yang D; Ding G; Liu J; Shang J; Kang Y; Ji X
Biomed Pharmacother; 2018 Nov; 107():1728-1735. PubMed ID: 30257391
[TBL] [Abstract][Full Text] [Related]
8. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
[TBL] [Abstract][Full Text] [Related]
9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
11. (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway.
Hsieh YC; Lee KC; Lei HJ; Lan KH; Huo TI; Lin YT; Chan CC; Schnabl B; Huang YH; Hou MC; Lin HC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):813-838. PubMed ID: 34087453
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice.
Wang J; Deng X; Yi S; Pathil A; Zhang W; Setchell K; Stremmel W; Chamulitrat W
Shock; 2015 Apr; 43(4):379-86. PubMed ID: 25526375
[TBL] [Abstract][Full Text] [Related]
13. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.
Chamulitrat W; Burhenne J; Rehlen T; Pathil A; Stremmel W
Hepatology; 2009 Jul; 50(1):143-54. PubMed ID: 19496180
[TBL] [Abstract][Full Text] [Related]
14. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation.
Cierpka R; Weiskirchen R; Asimakopoulos A
Cells; 2021 Aug; 10(9):. PubMed ID: 34571833
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different bile acid-phospholipid conjugates in acute hepatitis.
Pathil A; Warth A; Chamulitrat W; Stremmel W
Eur J Clin Invest; 2012 Feb; 42(2):130-8. PubMed ID: 21707612
[TBL] [Abstract][Full Text] [Related]
16. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
18. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against CD95/FAS-Induced Fulminant Hepatitis.
Utaipan T; Otto AC; Gan-Schreier H; Chunglok W; Pathil A; Stremmel W; Chamulitrat W
Shock; 2017 Aug; 48(2):251-259. PubMed ID: 28060213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
